{
  "id": "NGN_SA_HypoMyx_BATCH-300-154-1771349907771",
  "version": "2.0",
  "cpmmStep": "generateSolutions",
  "meta": {
    "topic": "Hypothyroidism/Myxedema",
    "type": "selectN",
    "difficulty": 4,
    "seed": "BATCH-300-154-1771349907771"
  },
  "stem": "The nurse is reviewing the client's data and developing a plan of care. The client has been diagnosed with myxedema coma.",
  "caseItem": {
    "id": "case_1771",
    "tabs": [
      {
        "id": "tab1",
        "title": "Nurse's Notes",
        "type": "nurseNotes",
        "content": {
          "timestamp": "Day 1, 09:00",
          "note": "A 77-year-old female with a history of Hashimoto's thyroiditis and medication non-adherence is brought to the emergency department by her family due to a 3-day history of progressive lethargy, confusion, and slurred speech. The family states the client has been feeling 'ice cold to the touch.' The client is minimally responsive to verbal stimuli but withdraws from painful stimuli. Skin is cool, dry, and pale with non-pitting edema noted on the face and lower extremities. Mucous membranes are dry."
        }
      },
      {
        "id": "tab2",
        "title": "Vital Signs & Diagnostics",
        "type": "vitalsAndDiagnostics",
        "content": {
          "vitals": [
            {
              "label": "Temperature",
              "value": "34.9째C (94.8째F)",
              "time": "09:05"
            },
            {
              "label": "Heart Rate",
              "value": "48 bpm",
              "time": "09:05"
            },
            {
              "label": "Blood Pressure",
              "value": "88/54 mmHg",
              "time": "09:05"
            },
            {
              "label": "Respiratory Rate",
              "value": "10 breaths/min",
              "time": "09:05"
            },
            {
              "label": "SpO2",
              "value": "91% on room air",
              "time": "09:05"
            }
          ],
          "diagnostics": [
            {
              "category": "Laboratory Results",
              "tests": [
                {
                  "name": "TSH",
                  "value": "154 mIU/L",
                  "reference": "0.4-4.2 mIU/L"
                },
                {
                  "name": "Free T4",
                  "value": "0.3 ng/dL",
                  "reference": "0.8-1.8 ng/dL"
                },
                {
                  "name": "Sodium",
                  "value": "122 mEq/L",
                  "reference": "136-145 mEq/L"
                },
                {
                  "name": "Glucose",
                  "value": "58 mg/dL",
                  "reference": "70-110 mg/dL"
                },
                {
                  "name": "ABG - pH",
                  "value": "7.28",
                  "reference": "7.35-7.45"
                },
                {
                  "name": "ABG - PaCO2",
                  "value": "55 mmHg",
                  "reference": "35-45 mmHg"
                }
              ]
            }
          ]
        }
      }
    ]
  },
  "selectN": {
    "question": "Which interventions should the nurse include in the immediate plan of care? Select all that apply.",
    "options": [
      {
        "id": "opt_1",
        "label": "Administer a rapid 1-liter bolus of 0.9% sodium chloride.",
        "rationale": "Incorrect. (-)\n\n**Pathophysiology:** Myxedema coma often presents with hyponatremia due to impaired water excretion. Rapid infusion of isotonic saline can worsen hyponatremia by diluting the already low sodium concentration. Additionally, the compromised cardiac function associated with myxedema makes the client vulnerable to fluid overload and heart failure.\n\n**Clinical Pearl:** Always assess sodium levels before administering large fluid boluses in myxedema coma. Hyponatremia should be addressed cautiously with hypertonic saline if symptomatic.",
        "score": "-1"
      },
      {
        "id": "opt_2",
        "label": "Prepare for intravenous administration of levothyroxine.",
        "rationale": "Correct. (+)\n\n**Pathophysiology:** Myxedema coma is a life-threatening manifestation of severe hypothyroidism. The primary defect is a deficiency of thyroid hormones (T4 and T3), leading to a profound decrease in metabolic rate and impaired function of multiple organ systems. IV levothyroxine (synthetic T4) provides immediate thyroid hormone replacement, which is crucial for reversing the hypometabolic state.\n\n**Clinical Pearl:** IV levothyroxine is preferred over oral administration in myxedema coma due to unreliable gastrointestinal absorption in critically ill patients. Monitor for signs of thyrotoxicosis (e.g., tachycardia, arrhythmias) during treatment.",
        "score": "1"
      },
      {
        "id": "opt_3",
        "label": "Apply a forced-air warming blanket set to high.",
        "rationale": "Incorrect. (-)\n\n**Pathophysiology:** Hypothermia is a common finding in myxedema coma due to decreased metabolic heat production and impaired thermoregulation. However, rapid rewarming with a forced-air warmer can cause peripheral vasodilation, leading to a further drop in blood pressure and cardiovascular collapse. This is because the body's compensatory mechanisms are already severely compromised.\n\n**Clinical Pearl:** Passive rewarming with blankets is the preferred method for treating hypothermia in myxedema coma. Monitor blood pressure closely during rewarming.",
        "score": "-1"
      },
      {
        "id": "opt_4",
        "label": "Initiate continuous cardiac and respiratory monitoring.",
        "rationale": "Correct. (+)\n\n**Pathophysiology:** Myxedema coma causes significant cardiovascular and respiratory depression. Bradycardia, hypotension, and hypoventilation are common. Continuous cardiac monitoring is essential to detect life-threatening arrhythmias (e.g., bradycardia, atrial fibrillation), and continuous respiratory monitoring (including pulse oximetry and capnography) is needed to assess and manage hypoventilation and respiratory acidosis.\n\n**Clinical Pearl:** Be prepared to provide ventilatory support (e.g., bag-valve-mask ventilation, intubation) if the client's respiratory status deteriorates.",
        "score": "1"
      },
      {
        "id": "opt_5",
        "label": "Prepare for administration of IV glucocorticoids.",
        "rationale": "Correct. (+)\n\n**Pathophysiology:** Myxedema coma can precipitate an adrenal crisis, particularly in clients with autoimmune thyroid disease (Hashimoto's thyroiditis), who may have concurrent adrenal insufficiency. The stress of severe hypothyroidism can overwhelm the adrenal glands' ability to produce cortisol. Administering thyroid hormone alone can increase cortisol demand and worsen an underlying adrenal insufficiency, leading to shock.\n\n**Clinical Pearl:** It is standard practice to administer IV glucocorticoids (e.g., hydrocortisone) empirically until adrenal insufficiency can be ruled out. Obtain baseline cortisol levels before administration, if possible.",
        "score": "1"
      },
      {
        "id": "opt_6",
        "label": "Administer a PRN dose of lorazepam for agitation.",
        "rationale": "Incorrect. (-)\n\n**Pathophysiology:** Clients in myxedema coma are extremely sensitive to the effects of sedatives, opioids, and anesthetics due to their reduced metabolic rate and impaired drug clearance. These medications can profoundly worsen respiratory depression and carbon dioxide retention, potentially leading to respiratory arrest.\n\n**Clinical Pearl:** Avoid sedatives and opioids in myxedema coma. If agitation is present, address the underlying causes (e.g., hypoxia, hyponatremia) and consider non-pharmacological interventions.",
        "score": "-1"
      },
      {
        "id": "opt_7",
        "label": "Prepare to administer hypertonic saline (3% NaCl).",
        "rationale": "Correct. (+)\n\n**Pathophysiology:** Hyponatremia is a common electrolyte imbalance in myxedema coma, often due to impaired free water excretion caused by increased ADH secretion and decreased renal blood flow. Symptomatic hyponatremia (e.g., altered mental status, seizures) requires cautious correction with hypertonic saline to prevent cerebral edema.\n\n**Clinical Pearl:** Administer hypertonic saline slowly and monitor sodium levels frequently to avoid overly rapid correction, which can lead to osmotic demyelination syndrome.",
        "score": "1"
      },
      {
        "id": "opt_8",
        "label": "Insert an indwelling urinary catheter.",
        "rationale": "Correct. (+)\n\n**Pathophysiology:** Clients in myxedema coma are critically ill and often have impaired renal function. Strict monitoring of intake and output is essential to guide fluid resuscitation, assess renal perfusion, and detect fluid overload. An indwelling urinary catheter allows for accurate hourly urine output measurement.\n\n**Clinical Pearl:** Monitor urine output closely and adjust fluid administration accordingly. Be aware of the risk of acute kidney injury in myxedema coma.",
        "score": "1"
      }
    ],
    "answer": [
      "opt_2",
      "opt_4",
      "opt_5",
      "opt_7",
      "opt_8"
    ]
  },
  "sbar": {
    "situation": "77-year-old female with Hashimoto's thyroiditis and medication non-adherence presenting to the ED with 3-day history of progressive lethargy, confusion, and slurred speech. Family reports client feels 'ice cold to the touch.'",
    "background": "Client is minimally responsive to verbal stimuli, withdrawing from pain. Skin is cool, dry, and pale with non-pitting edema on face and lower extremities. Mucous membranes are dry. Vital signs: Temp 34.9째C (94.8째F), HR 48 bpm, BP 88/54 mmHg, RR 10 breaths/min, SpO2 91% on room air.",
    "assessment": "Myxedema coma suspected based on history, clinical presentation, and lab results: TSH 154 mIU/L (high), Free T4 0.3 ng/dL (low), Sodium 122 mEq/L (low), Glucose 58 mg/dL (low), ABG pH 7.28 (acidic), PaCO2 55 mmHg (high).",
    "recommendation": "Initiate continuous cardiac and respiratory monitoring. Prepare for IV levothyroxine and glucocorticoid administration. Insert indwelling urinary catheter. Prepare for cautious administration of hypertonic saline. Avoid rapid rewarming and sedatives."
  },
  "sentinelStatus": "healed_v2026_v8"
}